MedTrace Logo

Prevalence Of Pulmonary Embolism In Patients With HEmoptysis (POPEIHE)

NCT06067997 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 550

Last updated 2023-10-05

No results posted yet for this study

Summary

Estimation of the incidence of pulmonary embolism in patients presenting to the Emergency Department with hemoptysis.

Conditions

Interventions

DIAGNOSTIC_TEST

pulmonary embolism diagnosis

The diagnosis of pulmonary embolism will be made using the diagnostic algorithm suggested by the 2019 European guidelines . The pre-test clinical probability of pulmonary embolism will be defined based on the simplified Wells score. In patients with a low pre-test clinical probability and a D-dimer level below the threshold value the diagnosis of pulmonary embolism will be excluded. The D-dimer level will be measured using the quantitative assay routinely used in each participating center; the threshold value for a positive result compared to a negative result is 500 μg per milliliter for patients under 50 years of age. For each additional decade of age, the exclusion cutoff will increase by 100 μg per milliliter. The criterion for the presence of pulmonary embolism is the detection of an intraluminal filling defect on CT.

Sponsors & Collaborators

  • Società Italiana di Medicina di Emergenza-Urgenza

    lead OTHER

Principal Investigators

  • Simone Vanni, Professor · University of Florence

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2023-04-30
Completion
2023-08-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06067997 on ClinicalTrials.gov